Evidence map›Paper›PMID 35599638›Full record

ArticleJournal of evolutionary biochemistry and physiology2022

Erratum to: Experimental Search for New Means of Pathogenetic Therapy COVID-19: Inhibitor of H2-Receptors Famotidine Increases the Effect of Oseltamivir on Survival and Immune Status of Mice Infected by A/PR/8/34 (H1N1).

N V Goncharov, K A Vasilyev, I V Kudryavtsev, P P Avdonin, D A Belinskaia, M A Stukova, O V Shamova, P V Avdonin

Open access · bronzeAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of evolutionary biochemistry and physiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

N V GoncharovSechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, St. Petersburg, Russia.
K A VasilyevSmorodintsev Research Institute of Influenza of the Ministry of Health of the Russian Federation, St. Petersburg, Russia.
I V KudryavtsevInstitute of Experimental Medicine, St. Petersburg, Russia.
P P AvdoninKoltsov Institute of Development Biology, Russian Academy of Sciences, Moscow, Russia.
D A BelinskaiaSechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, St. Petersburg, Russia.
M A StukovaSmorodintsev Research Institute of Influenza of the Ministry of Health of the Russian Federation, St. Petersburg, Russia.
O V ShamovaInstitute of Experimental Medicine, St. Petersburg, Russia.
P V AvdoninKoltsov Institute of Development Biology, Russian Academy of Sciences, Moscow, Russia.
Institute of Evolutionary Physiology and Biochemistry · RUInstitute of Experimental Medicine · RUKoltzov Institute of Developmental Biology · RUMinistry of Health of the Russian Federation · RUResearch Institute of Influenza · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.1134/S0022093022010203.].

Identifiers

PMID35599638
PMCPMC9109663
OpenAlexW4280504720

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.